ARKG ETF

ARKG identifies ARK Genomic Revolution ETF. The listed issuer is ARK. Review the fund prospectus for its objective, strategy and investment restrictions.

The Holdings tab presents available holdings for ARK Genomic Revolution ETF. Check the holdings date and weights; a partial list does not describe the entire portfolio or establish that it is diversified.

The available record reports an annual expense ratio of 0.75%. Confirm the current fee and any temporary waivers in the fund prospectus. Trading costs may be additional.

Check the issuer's distribution history for declared amounts and dates. A missing or zero yield in a data feed does not establish the distribution policy, frequency or future payments.

The recorded benchmark is Actively Managed. Verify the current benchmark and replication or active-management strategy with the issuer.

Review the prospectus for the fund's specific market, concentration, liquidity, currency and leverage risks where applicable. Past returns and fund size do not establish suitability or guarantee future returns.